{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T20:58:55Z","timestamp":1725569935011},"publisher-location":"Berlin, Heidelberg","reference-count":60,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642157561"},{"type":"electronic","value":"9783642157578"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"DOI":"10.1007\/7854_2010_73","type":"book-chapter","created":{"date-parts":[[2010,9,21]],"date-time":"2010-09-21T07:50:28Z","timestamp":1285055428000},"page":"263-283","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological Treatments for Bipolar Disorder: Present Recommendations and Future Prospects"],"prefix":"10.1007","author":[{"given":"Charles L.","family":"Bowden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,22]]},"reference":[{"key":"73_CR1","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1176\/appi.ajp.163.2.272","volume":"163","author":"MH Allen","year":"2006","unstructured":"Allen MH, Hirschfeld RM, Wozniak PJ et al (2006) Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania. Am J Psychiatry 163:272\u2013275","journal-title":"Am J Psychiatry"},{"key":"73_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/pst.310","volume":"7","author":"SA Barnes","year":"2008","unstructured":"Barnes SA, Mallinckrodt CH, Lindborg SR et al (2008) The impact of missing data and how it is handled on the rate of false-positive results in drug development. Pharm Stat 7:215\u2013225","journal-title":"Pharm Stat"},{"issue":"Suppl 13","key":"73_CR3","first-page":"4","volume":"57","author":"CL Bowden","year":"1996","unstructured":"Bowden CL (1996) Dosing strategies and time course of response to antimanic drugs. J Clin Psychiatry 57(Suppl 13):4\u20139","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 9","key":"73_CR4","first-page":"35","volume":"61","author":"CL Bowden","year":"2000","unstructured":"Bowden CL (2000) Efficacy of lithium in mania and maintenance therapy of bipolar disorder. J Clin Psychiatry 61(Suppl 9):35\u201340","journal-title":"J Clin Psychiatry"},{"key":"73_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.brainres.2008.05.084","volume":"1235","author":"CL Bowden","year":"2008","unstructured":"Bowden CL (2008) Bipolar pathophysiology and development of improved treatments: review and recommendations for innovative studies. Brain Res 1235:92\u201397","journal-title":"Brain Res"},{"key":"73_CR6","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.4088\/JCP.8125tx1c","volume":"70","author":"CL Bowden","year":"2009","unstructured":"Bowden CL (2009a) Diagnosis and impact of bipolar depression. J Clin Psychiatry 70:e32","journal-title":"J Clin Psychiatry"},{"key":"73_CR7","first-page":"17","volume":"8","author":"CL Bowden","year":"2009","unstructured":"Bowden CL (2009b) Help your bipolar disorder patients remain employed. Curr Psychiatry 8:17\u201325","journal-title":"Curr Psychiatry"},{"key":"73_CR8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1176\/ajp.153.6.765","volume":"153","author":"CL Bowden","year":"1996","unstructured":"Bowden CL, Janicak PG, Orsulak P et al (1996) Relation of serum valproate concentration to response in mania. Am J Psychiatry 153:765\u2013770","journal-title":"Am J Psychiatry"},{"key":"73_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/archpsyc.57.5.481","volume":"57","author":"CL Bowden","year":"2000","unstructured":"Bowden CL, Calabrese JR, McElroy SL et al (2000) A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry 57:481\u2013489","journal-title":"Arch Gen Psychiatry"},{"key":"73_CR10","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1038\/sj.npp.1300788","volume":"30","author":"CL Bowden","year":"2005","unstructured":"Bowden CL, Collins MA, McElroy SL et al (2005) Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium or placebo. Neuropsychopharmacology 30:1932\u20131939","journal-title":"Neuropsychopharmacology"},{"key":"73_CR11","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1176\/appi.ajp.163.7.1199","volume":"163","author":"CL Bowden","year":"2006","unstructured":"Bowden CL, Calabrese JR, Ketter TA et al (2006a) Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder. Am J Psychiatry 163:1199\u20131201","journal-title":"Am J Psychiatry"},{"key":"73_CR12","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.4088\/JCP.v67n1003","volume":"67","author":"Bowden CL, Swann AC, Calabrese JR, et al for the Depakote ER Mania Study Group","year":"2006","unstructured":"Bowden CL, Swann AC, Calabrese JR et al for the Depakote ER Mania Study Group (2006b) A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. J Clin Psychiatry 67:1501\u20131510","journal-title":"J Clin Psychiatry"},{"key":"73_CR13","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","volume":"64","author":"JR Calabrese","year":"2003","unstructured":"Calabrese JR, Bowden CL, Sachs G et al (2003) A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 64:1013\u20131024","journal-title":"J Clin Psychiatry"},{"key":"73_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/01.chi.0000194567.63289.97","volume":"45","author":"MP DelBello","year":"2006","unstructured":"DelBello MP, Kowatch RA, Adler CM et al (2006) A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry 45:305\u2013313","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"73_CR15","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.4088\/JCP.v67n1108","volume":"67","author":"MA Frye","year":"2006","unstructured":"Frye MA, Yatham LN, Calabrese JR et al (2006) Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials. J Clin Psychiatry 67:1721\u20131728","journal-title":"J Clin Psychiatry"},{"key":"73_CR16","unstructured":"Garfinkel SN, Ho SH, Wang X et al (2009) Cortisol facilitates memory by enhancing hippocampal activation and functional connectivity. ACNP Annual Meeting, Hollywood, Florida"},{"key":"73_CR17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0140-6736(10)60570-3","volume":"375","author":"JR Geddes","year":"2010","unstructured":"Geddes JR, Goodwin GM, Rendell J et al (2010) Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 375:385\u2013395","journal-title":"Lancet"},{"key":"73_CR18","volume-title":"Cognitive dysfunction in bipolar disorder: a guide for clinicians","author":"J Goldberg","year":"2008","unstructured":"Goldberg J, Burdick K (2008) Cognitive dysfunction in bipolar disorder: a guide for clinicians. American Psychiatric, Arlington, USA"},{"key":"73_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1176\/appi.ajp.2008.08050746","volume":"166","author":"JF Goldberg","year":"2009","unstructured":"Goldberg JF, Perlis RH, Bowden CL et al (2009) Manic symptoms during depressive episodes in 1, 380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiat 166:173\u2013181","journal-title":"Am J Psychiat"},{"key":"73_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.euroneuro.2008.03.003","volume":"18","author":"GM Goodwin","year":"2008","unstructured":"Goodwin GM, Anderson I, Arango C et al (2008) ECNP consensus meeting. Bipolar depression. Nice, March 2007. Eur Neuropsychopharmacol 18:535\u2013549","journal-title":"Eur Neuropsychopharmacol"},{"key":"73_CR21","first-page":"53","volume":"6","author":"J Greenhouse","year":"1992","unstructured":"Greenhouse J (1992) Clinical trials in psychiatry: should protocol deviation censor patient data? A comment. Am Coll Neuropsychol 6:53\u201357","journal-title":"Am Coll Neuropsychol"},{"key":"73_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/15622970902823202","volume":"10","author":"H Grunze","year":"2009","unstructured":"Grunze H, Vieta E, Goodwin GM et al (2009) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry 10:85\u2013116","journal-title":"World J Biol Psychiatry"},{"issue":"2","key":"73_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/15622970903555881","volume":"11","author":"H Grunze","year":"2010","unstructured":"Grunze H, Vieta E, Goodwin GM et al (2010) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry 11(2):81\u2013109","journal-title":"World J Biol Psychiatry"},{"key":"73_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4088\/JCP.v64n0209","volume":"64","author":"RM Hirschfeld","year":"2003","unstructured":"Hirschfeld RM, Lewis L, Vornik LA (2003) Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry 64:161\u2013174","journal-title":"J Clin Psychiatry"},{"key":"73_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/13651500500305622","volume":"9","author":"P Keck","year":"2005","unstructured":"Keck P, Meinhold J, Baker JL et al (2005) Relation of serum valproate and lithium concentrations to efficacy and tolerability in maintenance therapy for bipolar disorder. Int J Psychiatry Clin Pract 9:271\u2013277","journal-title":"Int J Psychiatry Clin Pract"},{"key":"73_CR26","first-page":"39","volume":"6","author":"PW Lavori","year":"1992","unstructured":"Lavori PW (1992) Clinical trials in psychiatry: should protocol deviation censor patient data? Neuropsychopharmacology 6:39\u201348","journal-title":"Neuropsychopharmacology"},{"key":"73_CR27","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1081\/CBI-200062413","volume":"22","author":"HA Mansour","year":"2010","unstructured":"Mansour HA, Wood J, Chowdari KV et al (2010) Circadian phase variation in bipolar I disorder. Chronobiol Int 22:571\u2013584","journal-title":"Chronobiol Int"},{"key":"73_CR28","first-page":"142","volume":"57","author":"SL McElroy","year":"1996","unstructured":"McElroy SL, Keck PE Jr, Stanton SP et al (1996) A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 57:142\u2013146","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 1","key":"73_CR29","first-page":"30","volume":"10","author":"S McElroy","year":"2008","unstructured":"McElroy S, Young AH, Carlsson A et al (2008) A double-blind, placebo-controlled study with acute and continuation phase of quetiapine and paroxetine in adults with bipolar depression (Embolden II). Bipolar Disord 10(Suppl 1):30\u201390","journal-title":"Bipolar Disord"},{"key":"73_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/00004714-200004000-00012","volume":"20","author":"B Muller-Oerlinghausen","year":"2000","unstructured":"Muller-Oerlinghausen B, Retzow A, Henn FA et al (2000) Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. J Clin Psychopharmacol 20:195\u2013203","journal-title":"J Clin Psychopharmacol"},{"key":"73_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jad.2007.08.003","volume":"107","author":"C O\u2019Donovan","year":"2008","unstructured":"O\u2019Donovan C, Gamham JC, Hajek T et al (2008) Antidepressant monotherapy in pre-bipolar depression: predictive value and inherent risk. J Affect Disord 107:293\u2013298","journal-title":"J Affect Disord"},{"key":"73_CR32","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s11055-008-9047-9","volume":"38","author":"GA Oganesyam","year":"2010","unstructured":"Oganesyam GA, Aristakesyan EA, Romanova IV et al (2010) The dopaminergic nigrostriatal system in sleep deprivation in cats. Neurosci Behav Physiol 38:785\u2013792","journal-title":"Neurosci Behav Physiol"},{"key":"73_CR33","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","volume":"159","author":"GS Sachs","year":"2002","unstructured":"Sachs GS, Grossman F, Ghaemi SN et al (2002) Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double -blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 159:1146\u20131154","journal-title":"Am J Psychiatry"},{"key":"73_CR34","unstructured":"Sachs G, Lombardo I, Yang R et al (2009) Learnings from the ziprasidone bipolar depression program. In: ISCTM 5th Annual Meeting, Arlington, VA, 3\u20135 Mar 2009"},{"key":"73_CR35","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s11920-008-0082-6","volume":"10","author":"RC Shelton","year":"2008","unstructured":"Shelton RC, Reddy R (2008) Adjunctive use of modafinil in bipolar patients: just another stimulant or not? Curr Psychiatry Rep 10:520\u2013524","journal-title":"Curr Psychiatry Rep"},{"key":"73_CR36","unstructured":"Singh V, Bowden C, Thompson P et al (2009) Randomized, double blind 8-month maintenance study of bipolar depression with lamotrigine or divalproex ER plus lamotrigine. In: ACNP Annual Meeting 2009"},{"key":"73_CR37","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1399-5618.2007.00490.x","volume":"9","author":"LA Smith","year":"2007","unstructured":"Smith LA, Cornelius V, Warnock A et al (2007) Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Bipolar Disord 9:394\u2013412","journal-title":"Bipolar Disord"},{"key":"73_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2009.10.033","volume":"122","author":"LA Smith","year":"2010","unstructured":"Smith LA, Cornelius VR, Azorin JM et al (2010) Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis. J Affect Disord 122:1\u20139","journal-title":"J Affect Disord"},{"key":"73_CR39","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1017\/S1092852900016965","volume":"13","author":"SM Stahl","year":"2008","unstructured":"Stahl SM, Felker A (2008) Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants. CNS Spectrum 13:855\u2013870","journal-title":"CNS Spectrum"},{"key":"73_CR40","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/nature04286","volume":"437","author":"R Stickgold","year":"2005","unstructured":"Stickgold R (2005) Sleep-dependent memory consolidation. Nature 437:1272\u20131278","journal-title":"Nature"},{"key":"73_CR41","doi-asserted-by":"publisher","first-page":"870","DOI":"10.4088\/JCP.v66n0710","volume":"66","author":"T Suppes","year":"2005","unstructured":"Suppes T, Dennehy EB, Hirschfled RMA et al (2005) The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiat 66:870\u2013886","journal-title":"J Clin Psychiat"},{"key":"73_CR42","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1176\/appi.ajp.2008.08020189","volume":"166","author":"T Suppes","year":"2009","unstructured":"Suppes T, Vieta E, Liu S et al (2009) Maintenance treatments for patients with bipolar I disorder: Results from a North American study of quetiapine in combination with lithium or divalproex (trial 127). Am J Psychiatry 166:476\u2013488","journal-title":"Am J Psychiatry"},{"key":"73_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/archpsyc.1997.01830130041008","volume":"54","author":"AC Swann","year":"1997","unstructured":"Swann AC, Bowden CL, Morris D et al (1997) Depression during mania: treatment response to lithium or divalproex. Arch Gen Psychiatry 54:37\u201342","journal-title":"Arch Gen Psychiatry"},{"key":"73_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0165-0327(01)00447-5","volume":"67","author":"A Swann","year":"2001","unstructured":"Swann A, Janicak P, Calabrese J et al (2001) Structure of mania: depressive, irritable, and psychotic clusters with different retrospectively-assessed course patterns of illness in randomized clinical trial participants. J Affect Disord 67:123\u2013132","journal-title":"J Affect Disord"},{"key":"73_CR45","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/01.jcp.0000248603.76231.b7","volume":"26","author":"ME Thase","year":"2006","unstructured":"Thase ME, Macfadden W, Weisler RH et al (2006) Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II Study). J Clin Psychopharmacol 26:600\u2013609","journal-title":"J Clin Psychopharmacol"},{"key":"73_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/jcp.0b013e3181618eb4","volume":"28","author":"ME Thase","year":"2008","unstructured":"Thase ME, Jonas A, Khan A et al (2008) Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies. J Clin Psychopharmacol 28:13\u201320","journal-title":"J Clin Psychopharmacol"},{"key":"73_CR47","unstructured":"Thase M, Calabrese JR, Bowden CL et al (2010) The NIMH bipolar trials network LiTMUS study: effectiveness of randomized adjunctive lithium in bipolar disorder. Presented at the NCDEU Annual Meeting 2007"},{"key":"73_CR48","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/archpsyc.59.1.62","volume":"59","author":"M Tohen","year":"2002","unstructured":"Tohen M, Chengappa KNR, Suppes T et al (2002) Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 59:62\u201369","journal-title":"Arch Gen Psychiatry"},{"key":"73_CR49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1192\/bjp.bp.107.041301","volume":"192","author":"M Tohen","year":"2008","unstructured":"Tohen M, Bowden CL, Smulevich AB et al (2008) Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes. Br J Psychiatry 192:135\u2013143","journal-title":"Br J Psychiatry"},{"key":"73_CR50","doi-asserted-by":"crossref","unstructured":"Tondo L, V\u00e1squez G, Baldessarini RJ (2009) Mania associated with antidepressant-treatment: comprehensive meta-analytic review. Acta Psychiatr Scand 121:404\u2013414","DOI":"10.1111\/j.1600-0447.2009.01514.x"},{"key":"73_CR51","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4088\/JCP.08m04152","volume":"70","author":"ML Loos van der","year":"2009","unstructured":"van der Loos ML, Mulder PG, Hartong EG et al (2009) Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. J Clin Psychiatry 70:223\u2013231","journal-title":"J Clin Psychiatry"},{"key":"73_CR52","doi-asserted-by":"crossref","unstructured":"Vieta E, Angst J, Azorin JM, et al for the BRIDGE Study Group (2010) Characteristics of patients with hypomanic symptoms presenting a current major depressive episode identified with the HCL-32 patient questionnaire. Presented at the European Psychiatric Association Meeting","DOI":"10.1016\/S0924-9338(10)71441-3"},{"key":"73_CR53","doi-asserted-by":"publisher","first-page":"8454","DOI":"10.1523\/JNEUROSCI.1443-08.2008","volume":"28","author":"ND Volkow","year":"2008","unstructured":"Volkow ND, Wang GJ, Telang F et al (2008) Sleep deprivation decreases binding of [11C]raclopride to dopamine D2\/D3 receptors in the human brain. J Neurosci 28:8454\u20138461","journal-title":"J Neurosci"},{"issue":"Suppl 1","key":"73_CR54","first-page":"148","volume":"55","author":"R Weisler","year":"2004","unstructured":"Weisler R, Warrington L, Dunn J (2004) Adjunctive ziprasidone in bipolar mania: short- and long-term data. Biol Psychiatry 55(Suppl 1):148","journal-title":"Biol Psychiatry"},{"key":"73_CR55","doi-asserted-by":"crossref","unstructured":"Weiss RD, Ostacher MJ, Otto MW, et al for the STEP-BD Investigators (2005) Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiat 66:730\u2013735","DOI":"10.4088\/JCP.v66n0609"},{"key":"73_CR56","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1192\/bjp.182.2.141","volume":"182","author":"LN Yatham","year":"2003","unstructured":"Yatham LN, Grossman F, Augustyns I et al (2003) Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial. Br J Psychiatry 182:141\u2013147","journal-title":"Br J Psychiatry"},{"key":"73_CR57","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/01.jcp.0000144887.66319.2f","volume":"24","author":"LN Yatham","year":"2004","unstructured":"Yatham LN, Paulsson B, Mullen J et al (2004) Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J Clin Psychopharmacol 24:599\u2013606","journal-title":"J Clin Psychopharmacol"},{"key":"73_CR58","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","volume":"11","author":"LN Yatham","year":"2009","unstructured":"Yatham LN, Kennedy SH, Schaffer A et al (2009) Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 11:225\u2013255","journal-title":"Bipolar Disord"},{"key":"73_CR59","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.biopsych.2004.03.013","volume":"56","author":"CA Zarate Jr","year":"2004","unstructured":"Zarate CA Jr, Payne JL, Singh J et al (2004) Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biol Psychiatry 56:54\u201360","journal-title":"Biol Psychiatry"},{"key":"73_CR60","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1399-5618.2007.00530.x","volume":"9","author":"CA Zarate","year":"2007","unstructured":"Zarate CA, Singh JB, Carlson PJ et al (2007) Efficacy of a protein kinase c inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. Bipolar Disord 9:561\u2013570","journal-title":"Bipolar Disord"}],"container-title":["Current Topics in Behavioral Neurosciences","Behavioral Neurobiology of Bipolar Disorder and its Treatment"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2010_73","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T23:46:39Z","timestamp":1559691999000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/7854_2010_73"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"ISBN":["9783642157561","9783642157578"],"references-count":60,"URL":"https:\/\/doi.org\/10.1007\/7854_2010_73","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"type":"print","value":"1866-3370"},{"type":"electronic","value":"1866-3389"}],"subject":[],"published":{"date-parts":[[2010]]}}}